The start-up ABRAM, co-founded by Prof. Thomas Leung Yun-chung from PolyU (right) and Prof. Alisa Shum Sau-wun from CUHK (left) being the first Hong Kong-based start-up joining the Roche Accelerator.
The Faculty celebrates the acceptance of ABRAM Therapeutics Limited (ABRAM), a start-up co-founded by a PolyU Science scholar, into the Roche Accelerator. This marks the first time a Hong Kong-based start-up being welcomed by this prestigious innovation hub. Co-founded by Prof. Thomas Leung Yun-chung, Professor of the Department of Applied Biology and Chemical Technology, Lo Ka Chung Charitable Foundation Professor in Pharmaceutical Sciences and Director of University Research Facility in Life Sciences, ABRAM focuses on its ground-breaking drug candidate, ABarginase, for treating obesity and related metabolic disorders such as diabetes and fatty liver disease. This milestone will significantly advance the development of the drug, paving the way for its clinical application to benefit patients worldwide.
Press Release: English | 中文
Online coverage:
| Hong Kong China News Agency | 1 Arpil 2025 |
|
| Zhihu |
破解肥胖困局！理大新药获罗氏加速器支持 |
1 Arpil 2025 |
